Retrospective Evaluation of the Implementation of a Digital Solution Supporting the Delivery of Pulmonary Rehabilitation Programs in Private Physiotherapy Practice

Brief summary (registry, in English)

Pulmonary rehabilitation improves exercise capacity, functional status, symptoms and quality of life in individuals with chronic respiratory diseases. However, access to pulmonary rehabilitation remains limited due to insufficient availability of specialized centers and geographical, organizational, logistical, and financial barriers. Delivering pulmonary rehabilitation in private physiotherapy practices may improve access to care, but implementation can be challenged by limited resources, equipment, and support tools. A field-based implementation program was conducted from summer 2025 to support physiotherapists in delivering pulmonary rehabilitation in private practice through the provision of a digital support solution (TELEREHAPP) and, where appropriate, associated equipment. During this program, physiotherapists collected data on solution use, patient characteristics, and available clinical follow-up indicators. Satisfaction and perceived usability were assessed among both physiotherapists and patients. This retrospective study aims to analyze the data already collected during the implementation program to evaluate the feasibility of implementation, use, and acceptability of the TELEREHAPP digital solution in private physiotherapy practice, and to describe changes in available clinical outcomes among participating patients.

What you commit to

• Study type: Observational
• Planned participants: 50
• From 1 Sept 2025 to the primary completion date, 1 Jun 2026
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.